Moderate

Lymphatic filariasis

Filariasis · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Lymphatic filariasis (Wuchereria bancrofti, Brugia species) is a mosquito-borne nematode infection causing lymphoedema, elephantiasis and hydrocele. Treatment clears microfilariae and controls morbidity; the role of doxycycline (anti-Wolbachia) is increasingly important.

Red flags

  • Severe reactions to DEC/ivermectin where loiasis co-infection present (encephalopathy)
  • Acute adenolymphangitis with sepsis
  • Rapidly worsening lymphoedema with cellulitis
  • Chyluria/renal involvement
  • Massive hydrocele causing obstruction

Assessment

Differential diagnosis

  • Non-filarial lymphoedema
  • Cellulitis/erysipelas
  • Deep vein thrombosis
  • Hydrocele of other cause
  • Tropical pulmonary eosinophilia (differential of its own form)

Investigations

  • Nocturnal thick blood film for microfilariae
  • Filarial antigen test (W. bancrofti)
  • Eosinophil count and IgE
  • Ultrasound (filarial dance sign; scrotal/lymphatic imaging)
  • Serology where available
  • Assess limb/lymphoedema severity and secondary infection

Management

  • Confirm infection with antigen testing and/or nocturnal blood film
  • Assess for active microfilaraemia versus chronic lymphatic damage
  • Exclude co-endemic loiasis/onchocerciasis before diethylcarbamazine (risk of severe reactions)
  • Treat microfilaraemia with appropriate anthelmintic regimen
  • Add doxycycline to target Wolbachia and improve outcomes where appropriate
  • Manage lymphoedema with hygiene, skin care, elevation and compression
  • Treat and prevent acute bacterial/fungal superinfection (adenolymphangitis)
  • Offer surgery for hydrocele
  • Provide morbidity-management and disability-prevention support
  • Counsel on vector avoidance and mass drug administration programmes
  • Monitor response and reactions to treatment
  • Arrange long-term limb-care follow-up

Drugs & doses

Diethylcarbamazine 6 mg/kg PO (single dose or divided course) - only where loiasis/onchocerciasis excluded
Ivermectin 200-400 microgram/kg + albendazole 400 mg (triple therapy with DEC where safe)
Doxycycline 200 mg PO daily for 4-6 weeks (anti-Wolbachia, macrofilaricidal effect)
Albendazole 400 mg PO as part of combination/mass drug administration

Disposition

Outpatient tropical medicine/ID; surgery for hydrocele; long-term lymphoedema care.

Complications & pitfalls

  • Chronic lymphoedema and elephantiasis
  • Hydrocele and genital disability
  • Recurrent bacterial adenolymphangitis
  • Chyluria
  • Psychosocial and economic impact

Exam pearls

  • Exclude loiasis before diethylcarbamazine/ivermectin to avoid fatal encephalopathy
  • Doxycycline (anti-Wolbachia) has macrofilaricidal benefit and reduces lymphoedema progression
  • Limb hygiene and skin care prevent disabling acute attacks
  • Antigen testing detects adult-worm infection even without microfilaraemia
  • Morbidity management matters even after parasites are cleared

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.